LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 181 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,336,000 | +106.5% | 9,843 | +215.0% | 0.07% | +200.0% |
| Q2 2018 | $647,000 | -12.0% | 3,125 | -56.8% | 0.02% | -23.3% |
| Q4 2016 | $735,000 | +51.2% | 7,234 | -20.8% | 0.03% | +87.5% |
| Q4 2014 | $486,000 | +50.0% | 9,130 | +32.5% | 0.02% | +60.0% |
| Q3 2014 | $324,000 | -71.0% | 6,892 | -61.6% | 0.01% | -66.7% |
| Q2 2014 | $1,118,000 | +117.9% | 17,953 | +135.6% | 0.03% | +114.3% |
| Q1 2014 | $513,000 | – | 7,620 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |